Chemotherapy-induced peripheral neurotoxicity: management informed by pharmacogenetics
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Chemotherapy-induced peripheral neurotoxicity: management informed by pharmacogenetics
Authors
Keywords
-
Journal
Nature Reviews Neurology
Volume 13, Issue 8, Pages 492-504
Publisher
Springer Nature
Online
2017-06-30
DOI
10.1038/nrneurol.2017.88
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Large-scale prospective pharmacogenomics study of oxaliplatin-induced neuropathy in colon cancer patients enrolled in the JFMC41-1001-C2 (JOIN Trial)
- (2016) M. Kanai et al. ANNALS OF ONCOLOGY
- A Genome-Wide Association Study Identifies a Novel Locus for Bortezomib-Induced Peripheral Neuropathy in European Patients with Multiple Myeloma
- (2016) F. Magrangeas et al. CLINICAL CANCER RESEARCH
- Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism that Increases Risk of Docetaxel-Induced Neuropathy
- (2016) D. L. Hertz et al. CLINICAL CANCER RESEARCH
- An Inherited Genetic Variant inCEP72Promoter Predisposes to Vincristine-Induced Peripheral Neuropathy in Adults With Acute Lymphoblastic Leukemia
- (2016) W Stock et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Comorbidities and Risk of Chemotherapy-Induced Peripheral Neuropathy Among Participants 65 Years or Older in Southwest Oncology Group Clinical Trials
- (2016) Dawn L. Hershman et al. JOURNAL OF CLINICAL ONCOLOGY
- Genetic Susceptibility to Bortezomib-Induced Peripheral Neuroropathy: Replication of the Reported Candidate Susceptibility Loci
- (2016) Chiara Campo et al. NEUROCHEMICAL RESEARCH
- Lack of association of the CEP72 rs924607 TT genotype with vincristine-related peripheral neuropathy during the early phase of pediatric acute lymphoblastic leukemia treatment in a Spanish population
- (2016) Angela Gutierrez-Camino et al. Pharmacogenetics and Genomics
- Vincristine pharmacokinetics pathway and neurotoxicity during early phases of treatment in pediatric acute lymphoblastic leukemia
- (2016) Elixabet Lopez-Lopez et al. PHARMACOGENOMICS
- Testing of candidate single nucleotide variants associated with paclitaxel neuropathy in the trial NCCTG N08C1 (Alliance)
- (2016) Ganesh K. Boora et al. Cancer Medicine
- Docetaxel-induced neuropathy: A pharmacogenetic case-control study of 150 women with early-stage breast cancer
- (2015) Lise Eckhoff et al. ACTA ONCOLOGICA
- Carfilzomib and pomalidomide in patients with relapsed and/or refractory multiple myeloma with baseline risk factors
- (2015) M. A. Dimopoulos et al. ANNALS OF ONCOLOGY
- Genome-Wide Association Studies for Taxane-Induced Peripheral Neuropathy in ECOG-5103 and ECOG-1199
- (2015) B. P. Schneider et al. CLINICAL CANCER RESEARCH
- Association of an Inherited Genetic Variant With Vincristine-Related Peripheral Neuropathy in Children With Acute Lymphoblastic Leukemia
- (2015) Barthelemy Diouf et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Association of the Charcot–Marie–Tooth disease gene ARHGEF10 with paclitaxel induced peripheral neuropathy in NCCTG N08CA (Alliance)
- (2015) Ganesh K. Boora et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Genetic determinants of chronic oxaliplatin-induced peripheral neurotoxicity: a genome-wide study replication and meta-analysis
- (2015) Salvatore Terrazzino et al. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
- Pharmacogenomics in the clinic
- (2015) Mary V. Relling et al. NATURE
- Paclitaxel-induced neuropathy: potential association of MAPT and GSK3B genotypes
- (2015) Susanna B Park et al. BMC CANCER
- Bortezomib- and thalidomide-induced peripheral neuropathy in multiple myeloma: clinical and molecular analyses of a phase 3 study
- (2014) Paola Tacchetti et al. AMERICAN JOURNAL OF HEMATOLOGY
- Sequencing of Charcot-Marie-Tooth disease genes in a toxic polyneuropathy
- (2014) Andreas S. Beutler et al. ANNALS OF NEUROLOGY
- Bortezomib-induced peripheral neurotoxicity: an update
- (2014) Andreas A. Argyriou et al. ARCHIVES OF TOXICOLOGY
- Replication of Genetic Polymorphisms Reported to Be Associated with Taxane-Related Sensory Neuropathy in Patients with Early Breast Cancer Treated with Paclitaxel
- (2014) J. E. Abraham et al. CLINICAL CANCER RESEARCH
- Neurotoxicity induced by antineoplastic proteasome inhibitors
- (2014) Albert Alé et al. NEUROTOXICOLOGY
- Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis
- (2014) Marta Seretny et al. PAIN
- Polymorphisms of the vincristine pathway and response to treatment in children with childhood acute lymphoblastic leukemia
- (2014) Francesco Ceppi et al. PHARMACOGENOMICS
- Genetic variation in platinating agent and taxane pathway genes as predictors of outcome and toxicity in advanced non-small-cell lung cancer
- (2014) Jatinder Kaur Lamba et al. PHARMACOGENOMICS
- Genetic markers for toxicity of adjuvant oxaliplatin and fluoropyrimidines in the phase III TOSCA trial in high-risk colon cancer patients
- (2014) Annamaria Ruzzo et al. Scientific Reports
- Chemotherapy-induced peripheral neuropathy in adults: a comprehensive update of the literature
- (2014) Andreas Argyriou et al. Cancer Management and Research
- The effect of race on the CYP3A-mediated metabolism of vincristine in pediatric patients with acute lymphoblastic leukemia
- (2014) Rosalyn P Sims JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Pharmacogenetic predictors of severe peripheral neuropathy in colon cancer patients treated with oxaliplatin-based adjuvant chemotherapy: a GEMCAD group study
- (2013) A. Custodio et al. ANNALS OF ONCOLOGY
- Voltage-gated sodium channel polymorphisms play a pivotal role in the development of oxaliplatin-induced peripheral neurotoxicity: Results from a prospective multicenter study
- (2013) Andreas A. Argyriou et al. CANCER
- Pharmacogenetic analysis of adjuvant FOLFOX for Korean patients with colon cancer
- (2013) Kyung-Hun Lee et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Clinical Pharmacogenetics Implementation Consortium Guidelines for Thiopurine Methyltransferase Genotype and Thiopurine Dosing: 2013 Update
- (2013) M V Relling et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Genetic polymorphisms of SLC28A3, SLC29A1 and RRM1 predict clinical outcome in patients with metastatic breast cancer receiving gemcitabine plus paclitaxel chemotherapy
- (2013) Soo-Youn Lee et al. EUROPEAN JOURNAL OF CANCER
- A Phase II Clinical Study of mFOLFOX6 Plus Bevacizumab as First-line Therapy for Japanese Advanced/Recurrent Colorectal Cancer Patients
- (2013) T. Nishina et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Genome-wide association study identifies ephrin type A receptors implicated in paclitaxel induced peripheral sensory neuropathy
- (2013) Luis J Leandro-García et al. JOURNAL OF MEDICAL GENETICS
- A Genome-Wide Association Study Identifies Novel Loci for Paclitaxel-Induced Sensory Peripheral Neuropathy in CALGB 40101
- (2012) R. M. Baldwin et al. CLINICAL CANCER RESEARCH
- Integration of Cell Line and Clinical Trial Genome-Wide Analyses Supports a Polygenic Architecture of Paclitaxel-Induced Sensory Peripheral Neuropathy
- (2012) H. E. Wheeler et al. CLINICAL CANCER RESEARCH
- Pharmacogenomics Knowledge for Personalized Medicine
- (2012) M Whirl-Carrillo et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Factors Exacerbating Peripheral Neuropathy Induced by Paclitaxel Plus Carboplatin in Non-small Cell Lung Cancer
- (2012) Kazuyoshi Kawakami et al. ONCOLOGY RESEARCH
- A prospective validation pharmacogenomic study in the adjuvant setting of colorectal cancer patients treated with the 5-fluorouracil/leucovorin/oxaliplatin (FOLFOX4) regimen
- (2012) E Cecchin et al. PHARMACOGENOMICS JOURNAL
- Germline polymorphisms in patients with advanced nonsmall cell lung cancer receiving first-line platinum-gemcitabine chemotherapy
- (2011) Markus Joerger et al. CANCER
- Polymorphic markers associated with severe oxaliplatin-induced, chronic peripheral neuropathy in colon cancer patients
- (2011) Hong-Hee Won et al. CANCER
- Impact of plasma and intracellular exposure and CYP3A4, CYP3A5, and ABCB1 genetic polymorphisms on vincristine-induced neurotoxicity
- (2011) Romain Guilhaumou et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Clinical Pharmacogenetics Implementation Consortium Guidelines for Thiopurine Methyltransferase Genotype and Thiopurine Dosing
- (2011) M V Relling et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Chemotherapy-induced peripheral neurotoxicity (CIPN): An update
- (2011) Andreas A. Argyriou et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Genetic factors underlying the risk of bortezomib induced peripheral neuropathy in multiple myeloma patients
- (2011) S. L. Corthals et al. HAEMATOLOGICA
- Genetic Factors Underlying the Risk of Thalidomide-Related Neuropathy in Patients With Multiple Myeloma
- (2011) David C. Johnson et al. JOURNAL OF CLINICAL ONCOLOGY
- Vincristine pharmacodynamics and pharmacogenetics in children with cancer: A limited-sampling, population modelling approach
- (2011) Andrew S Moore et al. JOURNAL OF PAEDIATRICS AND CHILD HEALTH
- Bortezomib plus rituximab versus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 trial
- (2011) Bertrand Coiffier et al. LANCET ONCOLOGY
- Impact on response and survival of DNA repair single nucleotide polymorphisms in relapsed or refractory multiple myeloma patients treated with thalidomide
- (2011) María Teresa Cibeira et al. LEUKEMIA RESEARCH
- Adverse interactions between antifungal azoles and vincristine: review and analysis of cases
- (2011) Brad Moriyama et al. MYCOSES
- Genetic variation associated with bortezomib-induced peripheral neuropathy
- (2011) Reyna Favis et al. Pharmacogenetics and Genomics
- Regulation of CCL2 Expression by an Upstream TALE Homeodomain Protein-Binding Site That Synergizes with the Site Created by the A-2578G SNP
- (2011) Stephen H. Page et al. PLoS One
- Mechanisms of peripheral neuropathy associated with bortezomib and vincristine in patients with newly diagnosed multiple myeloma: a prospective analysis of data from the HOVON-65/GMMG-HD4 trial
- (2010) Annemiek Broyl et al. LANCET ONCOLOGY
- Increased risk of vincristine neurotoxicity associated with low CYP3A5 expression genotype in children with acute lymphoblastic leukemia
- (2010) Akinbode Egbelakin et al. PEDIATRIC BLOOD & CANCER
- Single-Agent Bortezomib in Previously Untreated Multiple Myeloma: Efficacy, Characterization of Peripheral Neuropathy, and Molecular Correlations With Response and Neuropathy
- (2009) Paul G. Richardson et al. JOURNAL OF CLINICAL ONCOLOGY
- Genomic variation in myeloma: design, content, and initial application of the Bank On A Cure SNP Panel to detect associations with progression-free survival
- (2008) Brian Van Ness et al. BMC Medicine
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now